
### [MONDO:0001336](http://purl.obolibrary.org/obo/MONDO_0001336)
**Label:** familial hyperlipidemia

**Subclasses:** [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0011470](http://purl.obolibrary.org/obo/MONDO_0011470) (hyperlipidemia, combined, 2), [MONDO:0014412](http://purl.obolibrary.org/obo/MONDO_0014412) (hyperlipoproteinemia, type 1D), [MONDO:0009387](http://purl.obolibrary.org/obo/MONDO_0009387) (familial lipoprotein lipase deficiency), [MONDO:0011374](http://purl.obolibrary.org/obo/MONDO_0011374) (autosomal recessive hypercholesterolemia), [MONDO:0008810](http://purl.obolibrary.org/obo/MONDO_0008810) (familial apolipoprotein c-II deficiency), [MONDO:0007759](http://purl.obolibrary.org/obo/MONDO_0007759) (hyperlipidemia, familial combined), [MONDO:0007762](http://purl.obolibrary.org/obo/MONDO_0007762) (hyperlipoproteinemia type v), [MONDO:0007751](http://purl.obolibrary.org/obo/MONDO_0007751) (hypercholesterolemia, autosomal dominant, type b), [MONDO:0007761](http://purl.obolibrary.org/obo/MONDO_0007761) (hyperlipoproteinemia type IV), [MONDO:0007750](http://purl.obolibrary.org/obo/MONDO_0007750) (hypercholesterolemia, familial), [MONDO:0011369](http://purl.obolibrary.org/obo/MONDO_0011369) (hypercholesterolemia, autosomal dominant, 3), [MONDO:0011237](http://purl.obolibrary.org/obo/MONDO_0011237) (hyperlipidemia, combined, 1), [MONDO:0011207](http://purl.obolibrary.org/obo/MONDO_0011207) (xanthomatosis, susceptibility to), 

**Corr. equiv. classes:** [Orphanet:391665](http://www.orpha.net/ORDO/Orphanet_391665), [OMIM:602247](http://purl.obolibrary.org/obo/OMIM_602247), [OMIM:603776](http://purl.obolibrary.org/obo/OMIM_603776), [OMIM:604499](http://purl.obolibrary.org/obo/OMIM_604499), [Orphanet:309020](http://www.orpha.net/ORDO/Orphanet_309020), [OMIM:603813](http://purl.obolibrary.org/obo/OMIM_603813), [Orphanet:309015](http://www.orpha.net/ORDO/Orphanet_309015), [OMIM:144250](http://purl.obolibrary.org/obo/OMIM_144250), [OMIM:144010](http://purl.obolibrary.org/obo/OMIM_144010), [OMIM:207750](http://purl.obolibrary.org/obo/OMIM_207750), [OMIM:143890](http://purl.obolibrary.org/obo/OMIM_143890), [OMIM:615947](http://purl.obolibrary.org/obo/OMIM_615947), [OMIM:144600](http://purl.obolibrary.org/obo/OMIM_144600), [OMIM:238600](http://purl.obolibrary.org/obo/OMIM_238600), [OMIM:144650](http://purl.obolibrary.org/obo/OMIM_144650), [Orphanet:70470](http://www.orpha.net/ORDO/Orphanet_70470), [OMIM:602491](http://purl.obolibrary.org/obo/OMIM_602491), 

**Class expressions from DL-Learner:**

- [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) and [HP:0003124](http://purl.obolibrary.org/obo/HP_0003124) (Hypercholesterolemia) 56.38%
- [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) and [HP:0003107](http://purl.obolibrary.org/obo/HP_0003107) (Abnormality of cholesterol metabolism) 52.67%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) 51.62%
- [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) 51.47%
- [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 50.75%
- [HP:0003107](http://purl.obolibrary.org/obo/HP_0003107) (Abnormality of cholesterol metabolism) 47.09%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) 45.71%
- [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) and [HP:0012372](http://purl.obolibrary.org/obo/HP_0012372) (Abnormal eye morphology) 44.59%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) and [HP:0000991](http://purl.obolibrary.org/obo/HP_0000991) (Xanthomatosis) 44.59%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) 43.76%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) 43.57%
- [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 43.53%
- [HP:0003124](http://purl.obolibrary.org/obo/HP_0003124) (Hypercholesterolemia) 42.34%
- [HP:0010979](http://purl.obolibrary.org/obo/HP_0010979) (Abnormality of the level of lipoprotein cholesterol) 37.26%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 37.06%


